Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
about
Oral Leukoplakia as It Relates to HPV Infection: A ReviewNSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinomaBiomarkers of head and neck cancer, tools or a gordian knot?Lessons learned from next-generation sequencing in head and neck cancerOral premalignancy: the roles of early detection and chemopreventionGenome stability pathways in head and neck cancersMolecular changes in the multistage pathogenesis of head and neck cancerAdvances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.RETRACTED: Novel management of oral cancer: a paradigm of predictive oncology.Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.Targeting the epidermal growth factor receptor for head and neck cancer chemopreventionSingle nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.Allelic imbalance in oral lichen planus and assessment of its classification as a premalignant condition.Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial.Integrative molecular characterization of head and neck cancer cell model genomesMulti-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss.Phase II cancer prevention clinical trialsAbnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma.Activation of Akt at T308 and S473 in alcohol, tobacco and HPV-induced HNSCC: is there evidence to support a prognostic or diagnostic role?Deciphering squamous cell carcinoma using multidimensional genomic approaches.Molecular biology of squamous cell carcinoma of the head and neckApplication of cytology and molecular biology in diagnosing premalignant or malignant oral lesionsPhase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsCurrent concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma--a systematic review.Whole transcriptome sequencing identifies tumor-specific mutations in human oral squamous cell carcinoma.A novel target for oral cancer chemoprevention? Notch quite, yet….Early detection in head and neck cancer - current state and future perspectives.Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.Unique FISH patterns associated with cancer progression of oral dysplasia.Multiple head and neck tumors frequently originate from a single preneoplastic lesion.Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC).Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.Recent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.Malignant and nonmalignant gene signatures in squamous head and neck cancerTargeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities.Validation of LOH profiles for assessing oral cancer risk.Smoking and drinking in relation to oral cancer and oral epithelial dysplasia.The progress on genetic analysis of nasopharyngeal carcinoma.
P2860
Q21285037-A13E9BA1-49D0-4FD1-9766-9B1333749B2EQ21563424-FCAE7E4C-6DDB-4E11-B43F-594A0F8B25B0Q26784289-E53F2D82-FD45-4DEA-B6AA-6A7F6D41989DQ27009209-F3EF1013-BC8F-4A72-8138-CEB980276CA4Q27693327-585971EE-1BFB-4A40-BA0D-51DA9B9A5129Q28391355-2DD81B17-BBB6-4420-A762-5398AA8C597BQ28728638-DE974F43-669F-4827-9F7F-8BDF2C35CB11Q33610394-2AFE6C38-E276-4688-870D-88D1D78455AAQ33723572-95C7C3DB-648F-4D52-9F06-0FFC951AD170Q33817740-0DCAF146-1E7D-4D2A-ACB2-0CCF651F6C55Q33875694-A91C1E41-E75B-4035-B101-C1EA15A700D9Q33902184-0F0E7F03-4A61-487D-AAE5-2519B8529E29Q33911094-28BB8F48-EF90-4F01-88CB-758D7244182CQ33963253-91375CB9-244C-4BBF-8D4F-AFFCDC5D6B0CQ34057387-855C18BF-CCFA-4CAA-BAFC-7AD32879CDFDQ34091528-A24F1EF6-5438-4D9C-AEDD-C4950FD4B612Q34098286-2A48F469-4262-44B5-B9D2-42D3BBDEE26DQ34112511-B732D04D-9B8B-4635-B1FA-6968DB3E8C1AQ34344115-6C0BBC63-0CBE-4BD9-B8EC-E9C5D770169FQ34410251-2AA9488F-317A-4D81-A015-B6FD31D6EEC3Q34475613-84C1E785-BDD6-407F-BA77-F81DC038A0A7Q34518716-021D8D10-B238-461D-ABE0-03166034BA16Q34567480-EF21219C-5163-4EB2-902C-1A75CAE34EE5Q34568606-D814596B-167E-4D33-88AF-76AB1F1D347BQ34669387-4C4EA942-26EF-4655-B037-26B4AA07E88FQ34978926-6225A9E7-E8BF-4082-A54E-3EC79A311F98Q35251510-850A2FF4-D921-4C19-B591-DC81D6F860F0Q35427604-D7B80C17-6EAC-4936-8F22-0054CA145B07Q35585998-388C819D-60FD-4490-85C5-DF9933316AF6Q35586451-01338BAA-0EA6-4A65-A88D-E00D1A1B7966Q35596552-62CB8E8A-5B04-4964-9FA6-82378404CF6AQ35789054-04D37A86-9E3D-4E1C-9286-E66F8D5FB069Q35805764-A3ED1B65-F81A-4D7A-A5FB-C07B3C2B2360Q35821098-35605082-B348-43F4-BFE4-767A7D6854ECQ35825299-4377BEC4-E11D-4365-9BB9-0E6B91530E1BQ35909230-CB49A899-7D52-4C56-B21C-5CC227ECB33BQ35963741-49D86F75-510D-4C65-8989-9E918F214A0DQ36213589-DFDAB861-E586-4B2D-B4D8-05019B307441Q36274195-D21361CE-6791-4CC5-99A9-0E33A2B68E55Q36445020-A2CDF800-0200-4E6B-B5D4-4BCF075DDADF
P2860
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@ast
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@en
type
label
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@ast
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@en
prefLabel
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@ast
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
@en
P2093
P1476
Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
@en
P2093
Epstein JB
P304
P407
P577
2000-02-01T00:00:00Z